BUSINESSCNBC TOP
Wall Street stumbles as oil surges, and Lilly takes a new path on next-gen obesity drug
Wall Street experienced a decline as oil prices surged, and Eli Lilly and Company announced a new approach to developing a next-generation obesity drug. The Investing Club released its Homestretch update, providing afternoon trading insights.
Related Signal
Adjacent reporting
- Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
- Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead
- Eli Lilly stock surged after its next-generation weight loss drug posted record results
- Healthcare stocks have become a haven for investors ditching tech
- EM Stocks Tumble Most in More Than a Month as Oil Jumps
- New data boosts our confidence in Lilly's obesity pill. Plus, Google's new AI features